BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18374858)

  • 1. [Anicteric form of progressive familial intrahepatic cholestasis (Byler syndrome)].
    Masmoudi A; Hadj-Taieb I; Kammon T; Mseddi M; Boudaya S; Chaabouni M; Hachicha M; Turki H
    Ann Dermatol Venereol; 2008 Mar; 135(3):228-30. PubMed ID: 18374858
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementary stimulation of hepatobiliary transport and detoxification by rifampicin and ursodeoxycholic acid in humans.
    Duttala S; Tobi M; Dingell JD
    Gastroenterology; 2006 Feb; 130(2):619-20; author reply 620. PubMed ID: 16472623
    [No Abstract]   [Full Text] [Related]  

  • 3. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases.
    Berkane N; Cocheton JJ; Brehier D; Merviel P; Wolf C; Lefèvre G; Uzan S
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):941-6. PubMed ID: 11081677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment.
    Jain P
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716
    [No Abstract]   [Full Text] [Related]  

  • 5. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
    Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
    Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrahepatic cholestasis of pregnancy. New treatment].
    Ranek L; Ott P
    Ugeskr Laeger; 1999 Sep; 161(39):5411-2. PubMed ID: 10553352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
    Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
    Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G; Fehér R; Gardó S; Fehér J
    Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholestasis and eclampsia: a case report.
    Atabey S; Duvan CI; Eren U; Turhan NO
    Hypertens Pregnancy; 2007; 26(4):363-9. PubMed ID: 18066956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
    Ciocan D; Voican CS; Barbu V; Corpechot C; Rainteau D; Prevot S; Lebrun A; Perlemuter G
    Am J Gastroenterol; 2019 Sep; 114(9):1556-1559. PubMed ID: 31335361
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic cholestasis.
    Jansen PL; Sturm E
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S107-9. PubMed ID: 12817339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Marschall HU
    Scand J Gastroenterol; 2016; 51(2):256. PubMed ID: 26315148
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
    Colombo C; Vajro P; Degiorgio D; Coviello DA; Costantino L; Tornillo L; Motta V; Consonni D; Maggiore G;
    J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):73-83. PubMed ID: 21119540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid treatment in children with Byler disease.
    Dinler G; Koçak N; Ozen H; Yüce A; Gürakan F
    Pediatr Int; 1999 Dec; 41(6):662-5. PubMed ID: 10618887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis.
    Deng BC; Lv S; Cui W; Zhao R; Lu X; Wu J; Liu P
    World J Gastroenterol; 2012 Nov; 18(44):6504-9. PubMed ID: 23197899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
    Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholestasis of pregnancy: a case report.
    Konjeti R; Selsky N
    Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.